NovaBay Pharmaceuticals (NYSEMKT:NBY) is lower in late trading after the clinical-stage biopharmaceutical company said late Wednesday that it intends to offer shares of its common stock and warrants in an underwritten public offering. Shares are down 8.73% at $1.15, with a 52-week range of $0.76 – $2.03. The company intends to use the net proceeds…
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Net loss for the fourth quarter ended December 31, 2013 was $74.2 million, or $0.40 per share, compared to a net loss of $60.5 million, or $0.36 per share, for…
TrovaGene (NASDAQ:TROV) reported that for Q4, it narrowed its loss year over year, beating Street estimates, while revenue fell versus the prior year period and fell short of analysts’ expectations. The development-stage molecular diagnostic company reported a Q4 net loss of $1 million, or $0.05 per share, compared with the prior-year period’s net loss of…
Touchscreen, batteries and cameras – these are the most sensitive parts of smartphones. Here is a little guide on how to keep them safe during the cold period. Read More >>
Sirius XM Holdings Inc. (NASDAQ:SIRI) followed the broader equities market into the red yesterday, ending at $3.43 to match its lowest closing price of 2014. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock performance was -1.17% in last session and finished the day at $3.39. Traded volume was 84.61million shares in the last session and the average…
According to theflyonthewall.com Google (NASDAQ:GOOG) is establishing a new class of capital stock and is paying a dividend of one share of this new class of capital stock for each outstanding share of Class A and Class B common stock. Both Google Class A and Google Class C will be included in the S&P 500 and…
